Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Queensland Health
Federal Trade Commission
Cantor Fitzgerald
Chubb
Harvard Business School
Express Scripts
Teva
Deloitte

Generated: May 26, 2018

DrugPatentWatch Database Preview

Lomustine - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for lomustine and what is the scope of lomustine patent protection?

Lomustine
is the generic ingredient in one branded drug marketed by Corden Pharma and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for lomustine. One supplier is listed for this compound.
Pharmacology for lomustine
Drug ClassAlkylating Drug
Mechanism of ActionAlkylating Activity
Medical Subject Heading (MeSH) Categories for lomustine
Synonyms for lomustine
(Chloro-2-ethyl)-1-cyclohexyl-3-nitrosourea
(Cloro-2-etil)-1-cicloesil-3-nitrosourea
(Cloro-2-etil)-1-cicloesil-3-nitrosourea [Italian]
010L474
1-(2-Chloroethyl)-1-[(cyclohexylamino)carbonyl]-2-oxohydrazine #
1-(2-chloroethyl)-3-cyclohexyl-1-nitroso-ure
1-(2-chloroethyl)-3-cyclohexyl-1-nitroso-urea
1-(2-chloroethyl)-3-cyclohexyl-1-nitrosoure
1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea
1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea [Chloroethyl nitrosoureas]
1-(2-Chloroethyl)-3-cyclohexylnitrosourea
1-Nitrosourea, 1-(2-chloroethyl)-3-cyclohexyl-
13010-47-4
2-chloro-N-(cyclohexyl-C-hydroxycarbonimidoyl)-N-nitrosoethan-1-amine
3-(2-chloroethyl)-1-cyclohexyl-3-nitrosourea
4CH-007422
7BRF0Z81KG
A-2090
A806019
AB0013165
AB00173884_05
AB00173884_06
AB00173884-02
AB00173884-03
AB00173884-04
AB2000326
AC-8062
AC1L1H2T
ACN-048517
AI3-52779
AJ-45774
AK-72901
AKOS005766022
AM20070540
AN-8352
API0003206
Belustine
BR-72901
Bristol Myers Squibb Brand of Lomustine
Bristol-Myers Squibb Brand of Lomustine
BRN 2125058
C-13733
C07079
C9H16ClN3O2
CAS-13010-47-4
CC-30028
CCG-213022
CCNU
CCNU [Chloroethyl nitrosoureas]
CCNU;CeeNU
CCRIS 860
Cecenu
CeeNU
CeeNU (TN)
CeeNU, CCNU, Lomustine
CHEBI:6520
CHEMBL514
Chloroethylcyclohexylnitrosourea
CINU
CJ-10790
CS-1461
Cyclohexyl chloroethyl nitrosourea
D00363
D04JPJ
DB-017097
DB01206
DR000525
DS-1269
DSSTox_CID_3222
DSSTox_GSID_23222
DSSTox_RID_76930
DTXSID2023222
EINECS 235-859-2
FT-0083566
FT-0627972
GQYIWUVLTXOXAJ-UHFFFAOYSA-N
GTPL7214
H651
HMS2090A17
HMS3655I16
HSDB 6519
HY-13669
I06-0087
ICIG 1109
KB-146511
L0251
lomustin
Lomustina
Lomustina [INN-Spanish]
Lomustine (CeeNU)
Lomustine (USAN/INN)
Lomustine [USAN:BAN:INN]
Lomustine [USAN:INN:BAN]
Lomustine medac Brand
Lomustine, >=98%
Lomustine, European Pharmacopoeia (EP) Reference Standard
Lomustine, United States Pharmacopeia (USP) Reference Standard
Lomustinum
Lomustinum [INN-Latin]
LS-728
medac Brand of Lomustine
MFCD00012392
MolPort-001-768-818
N-(2-Chloroethyl)-N'-cyclohexyl-N-nitrosourea
NCGC00167466-01
NCGC00167466-02
NCGC00167466-03
NCI-C04740
NCI60_041743
NCIMech_000220
NPFAPI-06
NSC 79037
NSC-759635
NSC-79037
NSC759635
NSC79037
OR212490
OR5087
Pharmakon1600-01502301
RB 1509
Rhone Poulenc Rorer Brand of Lomustine
Rhone-Poulenc Rorer Brand of Lomustine
s1840
SC-12119
SCHEMBL3995
SR-05000001497
SR-05000001497-3
SRI 2200
ST24026836
TA-01004
Tox21_112470
Tox21_112470_1
UNII-7BRF0Z81KG
Urea, 1-(2-chloroethyl)-3-cyclohexyl-1-nitroso-
Urea, 1-(2-chloroethyl)-3-cyclohexyl)-1-nitroso-
Urea, N-(2-chloroethyl)-N'-cyclohexyl-N-nitroso-
W-108355
WLN: L6TJ AMVNNO&2G
ZINC3831006
ZX-AT016332

US Patents and Regulatory Information for lomustine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Corden Pharma GLEOSTINE lomustine CAPSULE;ORAL 017588-003 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Corden Pharma GLEOSTINE lomustine CAPSULE;ORAL 017588-004 Dec 19, 2014 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Corden Pharma GLEOSTINE lomustine CAPSULE;ORAL 017588-002 Approved Prior to Jan 1, 1982 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Corden Pharma GLEOSTINE lomustine CAPSULE;ORAL 017588-001 Approved Prior to Jan 1, 1982 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Express Scripts
Federal Trade Commission
Cantor Fitzgerald
Farmers Insurance
Harvard Business School
Baxter
US Department of Justice
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.